Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

New Drug More Effective in Treating Afib

May 2, 2016 10:10 am | by Medical University of Vienna | News | Comments

Vernakalant, a new drug for treating recent-onset atrial fibrillation, has proved to be considerably more effective than Ibutilide, an established drug in this indication.

TOPICS:

At the Vatican, Biden Seeks Common Cause with Pope on Cancer

May 2, 2016 9:47 am | by Josh Lederman, Associated Press | News | Comments

Vice President Joe Biden found common cause with Pope Francis on Friday at the Vatican for a global commitment to fund cancer research.

TOPICS:

FDA Reconsiders Training Requirements for Painkillers

May 2, 2016 8:41 am | by Matthew Perrone, AP Health Writer | News | Comments

The FDA first proposed its risk-management plan in 2010, before the CDC had formally identified opioid overdoses as a national epidemic.

TOPICS:
Advertisement

New Cancer Drugs Could Treat Lethal Resistant Prostate Cancers

May 2, 2016 8:38 am | by Institute of Cancer Research | News | Comments

The research suggests that Hsp90 inhibitors could be effective in prostate cancers that have become resistant to treatment and started spreading round the body.

TOPICS:

Scientists Discover Drugs that Could Fight Antibiotic-Resistant Bacteria

May 2, 2016 8:30 am | by Beth Israel Deaconess Medical Center | News | Comments

Investigators have developed a promising method of identifying new antimicrobials that target these organisms. 

TOPICS:

How Scientists Use DNA to Track Disease Outbreaks

May 2, 2016 8:28 am | by Emily Toth Martin, University of Michigan, The Conversation | News | Comments

Genetic sequencing allows us to determine how an infection travels – even tracing it across continents – with incredible precision.

TOPICS:

First Widely Available Zika Test Ok'd for Emergency Use

May 2, 2016 8:28 am | by The Associated Press | News | Comments

The first commercial test for the Zika virus has been cleared for emergency use in the U.S. and could be available by next week.

TOPICS:

EMA Recommends Approval for Biogen, AbbVie's MS Drug

May 1, 2016 11:30 am | News | Comments

The drug is also currently under regulatory review in the United States, Switzerland, Canada and Australia.

TOPICS:
Advertisement

Novo Nordisk Says US Launch 'Encouraging' as Profit Drops

April 29, 2016 10:30 am | News | Comments

The world's largest maker of diabetes treatments, Novo Nordisk, said on Friday that the US launch of ultra-long acting insulin Tresiba had been "encouraging" as it reported a drop in first quarter profit.

TOPICS:

New Non-Invasive Brain Stimulation Technique for Pain Management

April 29, 2016 10:27 am | by European Journal of Neuroscience | News | Comments

Researchers have discovered a new technique to enhance and maintain brain excitability that could increase sensory and pain threshold, which could be used to alleviate chronic pain in people who cannot take medication.

TOPICS:

Genomics Researchers Unveil Road Map to Disease Origin

April 29, 2016 10:19 am | by University of Arizona Health Sciences | News | Comments

Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer's and rheumatoid arthritis - and identifying new drug targets and therapies - thanks to work by three computational biology research teams.

TOPICS:

Scientists Turn Skin Cells into Heart, Brain Cells Using Drugs

April 29, 2016 10:15 am | by Gladstone Institutes | News | Comments

Scientists transformed skin cells into heart cells and brain cells using a combination of chemicals.

TOPICS:

Hawaii Looks to Allow Psychologists to Prescribe Drugs

April 29, 2016 10:09 am | by Marina Starleaf Riker, Associated Press | News | Comments

State lawmakers are poised to make Hawaii one of a handful of states that allow psychologists to prescribe medication in hopes of increasing access to mental health services.

TOPICS:

Gilead’s Profit Misses Target; HCV Drug Sales Disappoint

April 29, 2016 9:54 am | by Stephanie Guzowski, Editor | News | Comments

Gilead Sciences’s earnings missed analysts’ estimates, tumbling 17 percent in the first quarter. Lower sales of the biotech company’s blockbuster hepatitis C virus (HCV) drugs, Harvoni and Sovaldi, contributed to lower-than-expected profit.

TOPICS:

Diagnostic Screening for Alzheimer’s Disease: Economics, Policy, and Unanswered Questions

April 28, 2016 10:01 am | by Jillian Godfrey Scaife, Principal, and Nick Simmons-Stern, Consultant, Trinity Partners | Articles | Comments

In recent years, there has been a resurgence in the number of Alzheimer’s disease (AD) clinical trials, led by major efforts from Biogen, Lilly, Genentech/Roche, and others. With the first of these novel AD therapies potentially coming to market as early as 2017/2018, there are a number of critical and as yet unanswered questions surrounding the economics and policy of AD diagnostic screening. 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading